Highline Wealth Partners’s Select Medical SEM Stock Holding History

Highline Wealth Partners’s Portfolio SEM Stock Details SEM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.45K	Hold	209	–	–	﹤0.01%	965
2026 Q1	$3.4K	Hold	209	–	–	﹤0.01%	853
2025 Q4	$3.1K	Hold	209	–	–	﹤0.01%	718
2025 Q3	$2.68K	Hold	209	–	–	﹤0.01%	793
2025 Q2	$3.17K	Hold	209	–	–	﹤0.01%	553
2025 Q1	$3.49K	Hold	209	–	–	﹤0.01%	517
2024 Q4	$3.94K	Sell	209 -179	-46%	-$3.45K	﹤0.01%	380
2024 Q3	$7.29K	Hold	388	–	–	﹤0.01%	294
2024 Q2	$7.33K	Hold	388	–	–	﹤0.01%	252
2024 Q1	$6.3K	Hold	388	–	–	﹤0.01%	253
2023 Q4	$4.91K	Hold	388	–	–	﹤0.01%	250
2023 Q3	$5.28K	Buy	+388	New	+$5.99K	﹤0.01%	224

Other funds holding SEM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Verition Fund Management Greenwich, Connecticut $19.7B AUM 39.39% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

DAM

Decagon Asset Management London, United Kingdom $525M AUM 50.51% 1-Year Est. Return

PAMP

Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return

Highline Wealth Partners's SEM Position: Q2 2026 in Review

Highline Wealth Partners held its Select Medical (SEM) position steady in Q2 2026 at 209 shares worth $3.45K. The position accounts for ﹤0.01% of the portfolio, ranked #965.

Highline Wealth Partners first reported a position in SEM in Q3 2023 and has held it in 12 quarters since. The position peaked at $7.33K in Q2 2024. 238 funds tracked by Wall St. Rank hold SEM as of Q2 2026.

Highline Wealth Partners held 209 shares of Select Medical worth $3.45K as of Q2 2026.
Highline Wealth Partners left its Select Medical share count unchanged in Q2 2026.
Select Medical made up ﹤0.01% of Highline Wealth Partners's portfolio in Q2 2026, its #965 holding.
Highline Wealth Partners first reported a position in Select Medical in Q3 2023 and has held it in 12 quarters since.
Highline Wealth Partners's Select Medical position peaked at $7.33K in Q2 2024.
238 funds tracked by Wall St. Rank held Select Medical as of Q2 2026.

Based on Highline Wealth Partners's 13F filing for Q2 2026, filed 15 Jul 2026.